Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma

Basit Öğe Kaydı
dc.authoridSevinç, Alper/0000-0002-0499-8918
dc.authoridKAYA, Emin/0000-0001-8605-8497
dc.authorwosidSevinç, Alper/KPA-4519-2024
dc.authorwosidKAYA, Emin/W-2951-2017
dc.contributor.authorKuku, I
dc.contributor.authorKaya, E
dc.contributor.authorSevinc, A
dc.contributor.authorAydogdu, I
dc.date.accessioned2024-08-04T20:12:19Z
dc.date.available2024-08-04T20:12:19Z
dc.date.issued2002
dc.departmentİnönü Üniversitesien_US
dc.description.abstractGemcitabine is a nucleoside analogue that has shown to have antineoplastic activity in different solid tumours (lung, pancreas, bladder, colon, ovarian, and breast cancer) and malignant mesothelioma. The toxic effects of gemcitabine include myelosuppression, flu-like syndrome, altered liver function tests, bronchospasm, rash, itching, and fever. However, gemcitabine-induced erysipeloid skin reaction was reported in a small number of patients with previous history of radiotherapy or lymphedema. We reported a male patient who developed erysipeloid skin reaction following gemcitabine treatment in the absence of radiotherapy and lymphedema.en_US
dc.identifier.doi10.1046/j.1468-3083.2002.00485.x
dc.identifier.endpage272en_US
dc.identifier.issn0926-9959
dc.identifier.issue3en_US
dc.identifier.pmid12195570en_US
dc.identifier.scopus2-s2.0-0035996151en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage271en_US
dc.identifier.urihttps://doi.org/10.1046/j.1468-3083.2002.00485.x
dc.identifier.urihttps://hdl.handle.net/11616/93367
dc.identifier.volume16en_US
dc.identifier.wosWOS:000176955600016en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherEuropean Acad Dermatology & Venereologyen_US
dc.relation.ispartofJournal of The European Academy of Dermatology and Venereologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectgemcitabineen_US
dc.subjecterysipeloid skin reactionen_US
dc.subjectmalignant mesotheliomaen_US
dc.titleGemcitabine-induced erysipeloid skin lesions in a patient with malignant mesotheliomaen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu